Search results
Gen Xers will have higher cancer rates than boomers, study forecasts
LiveScience· 2 days agoGen Xers may be more likely to be diagnosed with cancer at 60 years old than their parents'...
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
Motley Fool via Yahoo Finance· 6 days agoAs it just launched, there hasn't been time for it to generate any revenue yet, though more than 100...
Addressing Cancer Screening Behaviors in the Musli | Newswise
Newswise· 2 days agoWASHINGTON (June 14, 2024) — An important study has revealed crucial insights into the cancer screening behaviors of Muslims in the Washington, D.C., area, highlighting the ...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 5 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
HUTCHMED (NASDAQ:HCM) Sees Large Volume Increase
ETF DAILY NEWS· 2 days agoHUTCHMED (China) Limited (NASDAQ:HCM – Get Free Report) saw strong trading volume on Wednesday . 314,021 shares were traded during trading, an increase of 153% from the previous session’s volume ...
Here's what a tumor actually is and why they're a lot more common than many people realize
USA TODAY via Yahoo News· 7 days ago"Cancer screening means checking your body for cancer before you have symptoms," notes the CDC....
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoOSLO, Norway, June 11, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced updates on its mRNA platform
What HPV means for sexually active individuals
Rolling Out· 7 days agoHuman Papillomavirus (HPV) is a common and significant concern for sexually active individuals worldwide. This virus can lead to various health issues,
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why | The Motley Fool
The Motley Fool· 6 days agoAs it just launched, there hasn't been time for it to generate any revenue yet, though more than 100 patients are enrolled for treatment, so it's only a matter of time. The ...
Dr. Roach: Bisphosphonates can cause esophageal disorders to worsen
Detroit News· 6 days agoDear C.M.C.: First off, we don’t usually treat isolated low bone mass (osteopenia) with powerful medicines like the ones you mention, which are both bisphosphonates. A person with low bone mass ...